IMU 1.89% 5.2¢ imugene limited

Ann: FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA, page-40

  1. 6 Posts.
    lightbulb Created with Sketch. 8
    So much news to get through over the last 48 hours, but I wonder if there has there been enough focus on the combination study with Keytruda here?

    Merck’s willingness to combine with Vaxinia at such an early stage is bloody exciting. Understandably it is early doors, and the science needs to play out, but US14B in annual sales in 2020 sure is something…
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.